Novavax, Inc. (NVAX)
8.87
-0.06
(-0.67%)
USD |
NASDAQ |
May 19, 11:34
Novavax Research and Development Expense (Quarterly) : 95.47M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Moderna, Inc. | 590.00M |
| Merck & Co., Inc. | 11.98B |
| Pfizer Inc. | 2.452B |
| AbbVie, Inc. | 2.472B |
| Intellia Therapeutics, Inc. | 78.54M |